LNP 1955
Alternative Names: LND 400111; LNP-1955; SUB177091Latest Information Update: 19 Feb 2022
At a glance
- Originator Lupin
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Plaque psoriasis; Rheumatoid arthritis
Most Recent Events
- 19 Feb 2022 No development reported - Phase-II for Plaque psoriasis in Hungary (PO)
- 19 Feb 2022 No development reported - Phase-II for Rheumatoid arthritis in Hungary (PO)
- 11 Oct 2017 Lupin completes a phase II trial in Plaque psoriasis in Hungary (PO) (EudraCT2016-001531-12)